Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics.

Takahata K, Tanaka E, Sakai R, Akazawa M.

Open source

DOI
10.1186/s13561-025-00710-y
Published
2025-12-19
Container
Health Econ Rev
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13561-025-00710-y,
  title = {Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics.},
  author = {Takahata K and  Tanaka E and  Sakai R and  Akazawa M.},
  year = {2025},
  journal = {Health Econ Rev},
  doi = {10.1186/s13561-025-00710-y},
  url = {https://doi.org/10.1186/s13561-025-00710-y}
}

RIS

TY  - JOUR
TI  - Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics.
AU  - Takahata K
AU  -  Tanaka E
AU  -  Sakai R
AU  -  Akazawa M.
PY  - 2025
JO  - Health Econ Rev
DO  - 10.1186/s13561-025-00710-y
UR  - https://doi.org/10.1186/s13561-025-00710-y
ER  - 

APA

K, T., E, T., R, S., & M., A. (2025). Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics.. Health Econ Rev. https://doi.org/10.1186/s13561-025-00710-y

Source records